Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Faron Pharmaceuticals Oy (FARN:LON) | 200 0 0.0% | Mkt Cap: 223.9m
Vadim Alexandre | Liam Gascoigne-Cohen
4 pages
Faron Pharma (FARN.L): Phase 2 interim results
Companies: Faron Pharmaceuticals Oy
Companies: PLI600258FARNMYE0CSRTCTOAMSLGENSNXSUSDPHFA/EKFANCRIMMAGYCTHSPHRSCLPABCCNENAPSDNLBBSNEUSPVLGHZDFDMPLUSBDRXHCMSQSE3C0NR1NEXNKYYWYPPIXQRTC4J
Companies: WJASEEPLI600258FARNMYE0CSRTAMSMEGPSYMDPHLGTEKFANCRIMMAGYTSTLCTHBOTBDOTDBVXPSCLPABCFULDNLVLGHZDVECSHOECAKESCSIDPTRCFISHJOULBDRXHCMHCHOF0NR1C4JMLM
Companies: FARN JLP COG VAL BUCE MWE HS9 AURR
